| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 620,426 | 580,817 | 612,226 | 606,359 | | Cost of Revenue | 372,520 | 352,149 | 362,091 | 374,645 | | | Gross Profit | 247,906 | 228,668 | 250,135 | 231,714 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 116,058 | 87,601 | 104,870 | 121,002 | | Non Recurring | (5,611) | 17,420 |
-
| 481,333 | | Others | 50,055 | 46,942 | 44,430 | 44,347 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 87,404 | 76,705 | 100,835 | (414,968) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,484) | 3,771 | 5,183 | 10,786 | | Earnings Before Interest And Taxes | 82,165 | 80,779 | 105,715 | (404,182) | | Interest Expense | 36,785 | 29,851 | 31,238 | 40,196 | | Income Before Tax | 45,380 | 50,928 | 74,477 | (444,378) | | Income Tax Expense | 24,029 | 22,448 | 33,816 | (65,805) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 16,997 | 28,480 | 40,661 | (378,573) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,351 | 28,480 | 40,661 | (378,573) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,351 | $28,480 | $40,661 | ($378,573) |
|
0.63% Nasdaq 
0.03%
Income Statement
